WELLESLEY HILLS, Massachusetts, February 5 /PRNewswire/ --

Joseph F. Finn, Jr., CPA, the Assignee for the Benefit of Creditors of ActivBiotics, announced today that The Committee for Orphan Drug Products of the European Medicines Agency (EMEA) has granted Orphan Drug Designation for M40403 for the prevention of oral mucositis (OM) in head and neck cancer patients receiving radiotherapy.

The development of oral mucositis during radiation therapy of head and neck cancers is the major reason for poor compliance with and early discontinuation of radiation therapy by patients being treated for their condition.

CHELMSFORD, Massachusetts, February 5 /PRNewswire/ --

- Companies team to simplify 3G home networking deployments

Airvana, Inc. (Nasdaq: AIRV), the company transforming the mobile experience, and Thomson (Euronext 18453; NYSE: TMS), a world leader in media and communications technologies, today announced that they entered into a global sourcing agreement for Airvana's Universal Mobile Telecommunication System (UMTS) femtocell technology. As a result of the agreement, Thomson will use Airvana's femtocell products in conjunction with their own residential gateways.

DUSSELDORF, Germany, February 5 /PRNewswire/ --

Arnaud de Meulemeester, who for the last three years has led the telematics program for PSA Peugeot Citroen, has been named Senior Director in Europe for ATX Group, the world's largest independent telematics provider to the automotive industry.

LONDON, February 5 /PRNewswire/ -- NHS Choices (http://www.nhs.uk), the online 'front door' to the NHS, today launched a new diabetes symptom checker.

Based on NHS accredited information, the diabetes symptom checker (http://www.nhs.uk/Tools/Pages/diabetes.aspx) enables users to find out in minutes whether they are at risk of having diabetes. It also provides them with clinically approved guidance on what their results mean and what next steps, if any, may be required. This interactive tool is the latest addition to the NHS Choices' extensive tool library.

MANCHESTER, England, February 5 /PRNewswire/ -- Epistem plc (LSE:EHP) announced today that it had successfully completed a preliminary study with AstraZeneca for the use of its proprietary, minimally invasive plucked human hair biomarker technology to help steer oncology drug development. The technology includes analysing gene expression change in RNA extracted from the bulb of cells located at the base of a single human plucked hair. Changes in gene expression can be used to identify biomarkers ('core gene sets') to aid decision-making in the drug development process.

CAMBERLEY, England, February 5 /PRNewswire/ -- Siemens today revealed a new site in North Hykeham as the proposed location for its industrial gas turbine business, demonstrating a long-term commitment to manufacturing in the area.

LONDON, February 5 /PRNewswire/ -- Moroc Soir is one of the leading publishing groups in the Kingdom of Morocco, with several newspaper and online titles notably the leading French Daily Le Matin and the Arabic dailies Assabah and Assahra Al Maghribiya. KnowledgeView is the leading publishing software and newspaper integrator in the Arab World with over 20 newspaper installations used by over 3000 journalists.

REDWOOD CITY, California, February 5 /PRNewswire/ --

- Mobile leaders team up to offer first ad-based open sourcepush email & PIM sync for consumers, prosumers and SMB

Funambol, the leading provider of Mobile 2.0 messaging software powered by open source, and Amobee Media Systems, the world leader in advertising solutions for mobile operators, today announced a partnership to enable operators and service providers to generate significant revenue from mobile email for the mass market.

LONDON, February 5 /PRNewswire/ --

- Axxia Acquisition Reinforces LexisNexis's Role as a Total Solutions Provider in the Mid-Sized Law Firm Market

LexisNexis, a leading global provider of business information solutions, today announced the acquisition of Axxia - a leading provider of back-office and integrated solutions in the mid-law segment in the UK.

The acquisition of Axxia enables LexisNexis to offer a full suite of practice management solutions to the UK mid-law sector. Medium sized law firms can now rely on LexisNexis for both content and complementary IT infrastructure enhanced with workflow solutions.

LONDON, February 5 /PRNewswire/ -- Oxford Computer Group (OCG) and Omada, partners and leading Microsoft Solution Providers for Identity and Access Management and Advanced Role Based Access Control, today announced that King's College London, one of the top 25 universities in the world, the fourth oldest in England and a member of the prestigious Russell Group, has successfully deployed Microsoft Identity Lifecycle Manager (ILM) and Omada Identity Manager (OIM) to provide a dramatically improved automatic provisioning and role-based user management system.